Global COPD and Asthma Diagnostic and Monitoring Devices Market (2020 to 2027) - by Product, Indication and End-user -

·4 min read

DUBLIN, Jun 21, 2021--(BUSINESS WIRE)--The "COPD and Asthma Diagnostic and Monitoring Devices Market by Product, Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to's offering.

The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to 2027.

Rise in lifestyle habits such as smoking & consumption of alcohol and growth in geriatric population are expected to boost the market growth. In addition, technological advances for new devices, regulatory approvals, and product launches are further promoting the market growth. In addition, prevalence of air pollution, climate changes, and dust fuels the market growth. Moreover, prevalence of respiratory diseases is increasing across the globe. In 2017, according to the WHO, respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from COPD and 3 million are expected to die from it each year, making it the third leading cause of death across the globe.

Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally. Rise in disposable income and increase in healthcare investments by governments & private organizations are anticipated to propel the market growth.

Factors such as rise in prevalence of respiratory diseases, huge demand for enhanced portable devices, growth in geriatric population, and high prevalence of tobacco smoking are expected to drive the market growth during the forecast period. The market is witnessing the emerging trend for spirometers, electrocardiogram, peak flow meter, polysomnography devices, and arterial blood gas analyzer, which is helping in providing real-time monitoring.

The global COPD and asthma diagnostics and monitoring devices market is segmented on the basis of product, indication, end user, and region. Based on the product, the market is segmented into diagnostic devices, monitoring devices, and consumables and accessories. Furthermore, the diagnostic devices segment includes spirometers electrocardiogram, FeNo test analyzer, peak flow meter, arterial blood gas analyzer (ABG), polysomnography devices, and others. The monitoring devices segment includes pulse oximeters, capnograph, asthma monitors, portable table top pulse oximeter, wearable devices, Fourier transform infrared spectroscopy (FTIR), and others.

The consumables and accessories segment includes masks, spirometry accessories, polysomnography accessories, peak flow meter accessories, pulse oximeter sensors, capnography accessories, gas analyzer accessories, and others. Based on indication, the market is divided into asthma and COPD. Based on end user, it is segregated into hospitals & clinics, home care settings, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries.

Key Benefits

  • The study provides an in-depth analysis of the global COPD and asthma diagnostics and monitoring devices market along with the current trends and future estimations to elucidate the imminent investment pockets.

  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.

  • Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

  • Extensive analysis of the key segments of the industry helps in understanding the forms and types of cell therapy used across the globe.

  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Market Dynamics


  • Daily exposure to environmental pollution

  • Increase in population susceptible to indoor air pollutants

  • Portability of the drug delivery devices

  • Increase in population of active smokers

  • Growth in number of surgeries


  • High costs of the device

  • Stringent regulatory procedures


  • High growth potential in emerging markets

  • Increase in geriatric population

Key Players Profiled

  • Becton Dickinson And Company

  • Dragerwerk AG & CO. KGAA

  • Getinge AB

  • Invacare Corporation

  • Masimo Corporation

  • Medtronic PLC

  • Koninklijke Philips N.V

  • Nihon Kohden Corporation

  • Smiths Medical

  • Vyaire Medical INC

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting